Financial Ratios Grupo de Inversiones Suramericana S.A.
Equities
GRUPOSURA
COT13PA00086
Life & Health Insurance
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52,400.00 COP | +0.77% |
|
-3.32% | -2.96% |
| 03-02 | Colombia's Grupo Argos posts 29% dip in Q4 profit | RE |
| 02-26 | Grupo de Inversiones Suramericana S.A. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.44 | 2.16 | 2.64 | 3.05 | 3.41 | |||||
Return on Total Capital | 2.57 | 3.89 | 5.33 | 6.47 | 7.61 | |||||
Return On Equity % | 1.21 | 5.07 | 7.22 | 5.96 | 20.96 | |||||
Return on Common Equity | 0.9 | 5.13 | 6.67 | 5.11 | 21.31 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 40.27 | 39.13 | 36.27 | 40.68 | 41.5 | |||||
SG&A Margin | 26.39 | 24.82 | 21.39 | 23.51 | 22.73 | |||||
EBITDA Margin % | 9.2 | 12.55 | 13.58 | 14.08 | 17.26 | |||||
EBITA Margin % | 8.78 | 10.36 | 11.74 | 13.78 | 15.59 | |||||
EBIT Margin % | 7.77 | 10.34 | 11.74 | 13.17 | 15.59 | |||||
Income From Continuing Operations Margin % | 1.66 | 6.17 | 7.42 | 5.72 | 19.28 | |||||
Net Income Margin % | 1.09 | 5.73 | 6.62 | 4.33 | 18.3 | |||||
Net Avail. For Common Margin % | 1.12 | 5.7 | 6.55 | 4.61 | 18.29 | |||||
Normalized Net Income Margin | 1.87 | 4.5 | 4.5 | 5.27 | 5.72 | |||||
Levered Free Cash Flow Margin | 3.28 | 11.08 | 30.25 | 0.59 | 21.35 | |||||
Unlevered Free Cash Flow Margin | 5.49 | 12.95 | 32.23 | 2.58 | 24.09 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.3 | 0.33 | 0.36 | 0.37 | 0.35 | |||||
Fixed Assets Turnover | 10.95 | 13.25 | 16.2 | 18.52 | 17.62 | |||||
Receivables Turnover (Average Receivables) | 3.82 | 3.98 | 4.06 | 4.43 | 4.36 | |||||
Inventory Turnover (Average Inventory) | 466.57 | 395.1 | - | 657.39 | - | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.19 | 0.84 | 0.53 | 0.86 | 3.44 | |||||
Quick Ratio | 0.91 | 0.8 | 0.3 | 0.69 | 2.05 | |||||
Operating Cash Flow to Current Liabilities | 0.08 | 0.09 | 0.2 | 0.04 | 0.9 | |||||
Days Sales Outstanding (Average Receivables) | 95.88 | 91.79 | 89.83 | 82.3 | 83.9 | |||||
Days Outstanding Inventory (Average Inventory) | 0.78 | 0.92 | - | 0.56 | - | |||||
Average Days Payable Outstanding | 281.89 | 296.47 | 676.98 | 264.68 | 83.06 | |||||
Cash Conversion Cycle (Average Days) | -185.23 | -203.75 | - | -181.82 | - | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 39.45 | 33.74 | 31.93 | 32.9 | 46.53 | |||||
Total Debt / Total Capital | 28.29 | 25.23 | 24.2 | 24.75 | 31.76 | |||||
LT Debt/Equity | 32.19 | 31.39 | 31.93 | 23.4 | 46.53 | |||||
Long-Term Debt / Total Capital | 23.09 | 23.47 | 24.2 | 17.6 | 31.76 | |||||
Total Liabilities / Total Assets | 59.77 | 58.81 | 63.63 | 65.31 | 70.3 | |||||
EBIT / Interest Expense | 2.2 | 3.46 | 3.7 | 4.15 | 3.55 | |||||
EBITDA / Interest Expense | 2.8 | 4.2 | 4.28 | 4.58 | 3.93 | |||||
(EBITDA - Capex) / Interest Expense | 2.62 | 4.01 | 4.13 | 4.46 | 3.85 | |||||
Total Debt / EBITDA | 5.5 | 3.42 | 2.68 | 2.06 | 2.32 | |||||
Net Debt / EBITDA | 3.96 | 2.68 | 1.85 | 1.43 | 1.8 | |||||
Total Debt / (EBITDA - Capex) | 5.88 | 3.59 | 2.78 | 2.12 | 2.38 | |||||
Net Debt / (EBITDA - Capex) | 4.24 | 2.81 | 1.91 | 1.46 | 1.84 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -2.26 | 19.02 | 26.4 | 21.73 | -6.02 | |||||
Gross Profit, 1 Yr. Growth % | -10.04 | 15.71 | 26.34 | 21.06 | 4.6 | |||||
EBITDA, 1 Yr. Growth % | -40.5 | 44.24 | 36.2 | 25.34 | 11.02 | |||||
EBITA, 1 Yr. Growth % | -41.7 | 57.77 | 42.54 | 25.82 | 13.43 | |||||
EBIT, 1 Yr. Growth % | -44.41 | 57.42 | 42.54 | 26.06 | 13.43 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -78.65 | 342.46 | 52.99 | -12.71 | 223.94 | |||||
Net Income, 1 Yr. Growth % | -85.24 | 525.68 | 47.31 | -25.8 | 294.52 | |||||
Normalized Net Income, 1 Yr. Growth % | -68.35 | 184.62 | 25.04 | 30.61 | 5.3 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -83.59 | 507.36 | 46.38 | -20.46 | 463.32 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -6.38 | 2.73 | 5.92 | -7.29 | 4.01 | |||||
Inventory, 1 Yr. Growth % | 244.96 | -15.91 | - | -8.92 | - | |||||
Accounts Receivable, 1 Yr. Growth % | 10.78 | 11.22 | 37 | -25.06 | 8.98 | |||||
Total Assets, 1 Yr. Growth % | 2.76 | 7.11 | 29.63 | -4.97 | 2.98 | |||||
Common Equity, 1 Yr. Growth % | 1.44 | 9.97 | 20.84 | -9.86 | -12.7 | |||||
Tangible Book Value, 1 Yr. Growth % | 1.6 | 13.28 | 15.91 | -6.18 | -16.79 | |||||
Cash From Operations, 1 Yr. Growth % | -23.31 | 18.51 | 354.57 | -86.58 | 243.1 | |||||
Capital Expenditures, 1 Yr. Growth % | -31.48 | 6.58 | 5.61 | -3.13 | -20.35 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -85.55 | -65.96 | -33.09 | -102.38 | -136.66 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -77.93 | -62.37 | -30.97 | -111.12 | -142.93 | |||||
Dividend Per Share, 1 Yr. Growth % | 3.5 | 29.93 | 63.27 | 9.38 | 7.14 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.69 | 7.67 | 23.23 | 19.69 | 6.63 | |||||
Gross Profit, 2 Yr. CAGR % | -12.62 | 1.82 | 16.98 | 26.72 | 7.41 | |||||
EBITDA, 2 Yr. CAGR % | -19.53 | -1.88 | 41.14 | 26.5 | 19.81 | |||||
EBITA, 2 Yr. CAGR % | -36.53 | -9.66 | 51.07 | 37.71 | 15.29 | |||||
EBIT, 2 Yr. CAGR % | -20.56 | -6.37 | 51.07 | 34.58 | 18.08 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -50.62 | -2.8 | 160.41 | 15.64 | 65.75 | |||||
Net Income, 2 Yr. CAGR % | -56.37 | -3.91 | 203.6 | 4.55 | 71.09 | |||||
Normalized Net Income, 2 Yr. CAGR % | -34.46 | -5.04 | 90.5 | 28.91 | 14.98 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -56.87 | -0.18 | 198.46 | 7.98 | 107.91 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 21.69 | -1.93 | 4.31 | -0.91 | -1.8 | |||||
Inventory, 2 Yr. CAGR % | 94.35 | 70.33 | - | - | - | |||||
Accounts Receivable, 2 Yr. CAGR % | -2.06 | 11 | 23.43 | 0.42 | -8.52 | |||||
Total Assets, 2 Yr. CAGR % | -0.09 | 4.85 | 17.84 | 10.99 | -1.07 | |||||
Common Equity, 2 Yr. CAGR % | 3.08 | 5.61 | 13.88 | 4.37 | -11.29 | |||||
Tangible Book Value, 2 Yr. CAGR % | 9.59 | 7.28 | 12.68 | 4.28 | -11.64 | |||||
Cash From Operations, 2 Yr. CAGR % | -46.74 | -6.83 | 118.13 | -21.9 | -24.62 | |||||
Capital Expenditures, 2 Yr. CAGR % | -5.86 | -14.54 | 6.09 | -0.25 | -5.71 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -46.43 | -23.91 | 8.88 | -87.79 | -10.58 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -35.81 | -21.4 | 9.31 | -74.98 | -1.52 | |||||
Dividend Per Share, 2 Yr. CAGR % | 4.74 | 15.96 | 45.65 | 33.63 | 8.25 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 1.98 | 8.44 | 13.94 | 19.84 | 10.19 | |||||
Gross Profit, 3 Yr. CAGR % | -6.67 | -4.17 | 7.03 | 20.26 | 15.23 | |||||
EBITDA, 3 Yr. CAGR % | -15.19 | 1.57 | 9.96 | 32.77 | 22.37 | |||||
EBITA, 3 Yr. CAGR % | -15.7 | -17.38 | 5.68 | 44.8 | 26.06 | |||||
EBIT, 3 Yr. CAGR % | -15.17 | -0.16 | 8.32 | 42.6 | 26.06 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -35.99 | 2.56 | 13.13 | 80.97 | 61.45 | |||||
Net Income, 3 Yr. CAGR % | -43.62 | 5.99 | 10.8 | 89.81 | 62.77 | |||||
Normalized Net Income, 3 Yr. CAGR % | -24.92 | 6.96 | 4.76 | 68.96 | 18.93 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -40.65 | 4.16 | 13.48 | 92.16 | 85.05 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 16.61 | 15.01 | 0.62 | 0.29 | 0.71 | |||||
Inventory, 3 Yr. CAGR % | 42.05 | 47 | - | -9.42 | - | |||||
Accounts Receivable, 3 Yr. CAGR % | -0.97 | 2.18 | 19.06 | 3.89 | 4.03 | |||||
Total Assets, 3 Yr. CAGR % | 0.93 | 2.22 | 12.54 | 9.68 | 8.26 | |||||
Common Equity, 3 Yr. CAGR % | 2.95 | 5.33 | 9.57 | 5.35 | -1.66 | |||||
Tangible Book Value, 3 Yr. CAGR % | 8.09 | 10.8 | 8.86 | 6.01 | -3.28 | |||||
Cash From Operations, 3 Yr. CAGR % | 14.49 | -31.53 | 51.61 | -13.89 | 37.21 | |||||
Capital Expenditures, 3 Yr. CAGR % | -0.54 | -1.88 | -8.29 | 1.98 | -2.98 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -24.96 | 4.77 | 26.33 | -70.22 | -20.64 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -2.01 | 4.87 | 25.18 | -52.32 | -18.26 | |||||
Dividend Per Share, 3 Yr. CAGR % | 5.22 | 12.54 | 29.97 | 32.39 | 24.14 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.96 | 6.51 | 9.92 | 13.02 | 9.38 | |||||
Gross Profit, 5 Yr. CAGR % | 2.18 | 1.7 | 2.07 | 5.75 | 8.23 | |||||
EBITDA, 5 Yr. CAGR % | -6.71 | 2.03 | 6.39 | 11.2 | 12.34 | |||||
EBITA, 5 Yr. CAGR % | -7.19 | -1.32 | 3.94 | 1.65 | 10.65 | |||||
EBIT, 5 Yr. CAGR % | -8.29 | 0.31 | 6.89 | 12.89 | 12.3 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -23.68 | -0.97 | 12.21 | 7.64 | 31.84 | |||||
Net Income, 5 Yr. CAGR % | -27.24 | -0.5 | 10.56 | 5.41 | 31.83 | |||||
Normalized Net Income, 5 Yr. CAGR % | -16.73 | 1.28 | 8.98 | 15.7 | 9.11 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -26.98 | 0.37 | 13.24 | 5.71 | 44.62 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 14.89 | 12.62 | 11.52 | 8.36 | -0.36 | |||||
Inventory, 5 Yr. CAGR % | 27.64 | 20.11 | - | 22.93 | - | |||||
Accounts Receivable, 5 Yr. CAGR % | 20.56 | 4.72 | 8.15 | 1.47 | 6.77 | |||||
Total Assets, 5 Yr. CAGR % | 5.02 | 2.37 | 7.36 | 5.64 | 6.88 | |||||
Common Equity, 5 Yr. CAGR % | 2.63 | 4.76 | 7.19 | 4.43 | 0.7 | |||||
Tangible Book Value, 5 Yr. CAGR % | 3.35 | 6.91 | 9.9 | 7.42 | 0.14 | |||||
Cash From Operations, 5 Yr. CAGR % | -15.33 | -20.26 | 46.81 | -29.6 | 14.64 | |||||
Capital Expenditures, 5 Yr. CAGR % | 1.09 | -2.77 | 2.06 | -1.23 | -7.78 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 32.74 | 38.66 | 42.6 | -38.33 | 8.54 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 140.86 | 73.92 | 52.92 | -19.78 | 9.19 | |||||
Dividend Per Share, 5 Yr. CAGR % | 5.76 | 9.95 | 19.83 | 20.55 | 20.8 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















